Horizon Discovery Group plc Director/PDMR Shareholding (2175N)
07 August 2017 - 4:00PM
UK Regulatory
TIDMHZD
RNS Number : 2175N
Horizon Discovery Group plc
07 August 2017
Horizon Discovery Group plc
Director/PDMR Shareholding
Cambridge, UK, 7 August 2017: Horizon Discovery Group plc (LSE:
HZD) ("Horizon" or the "Company"), a global leader in the
application of gene editing technologies, today announces that
Richard Vellacott, Chief Financial Officer, was granted options
under the Horizon Discovery 2014 Sharesave Scheme over Horizon
Discovery Group plc ordinary shares of 1p each as detailed
below:
No. of Option Exercisable
shares Exercise Date
under option Price
Richard 10,638 GBP1.692 1 September
Vellacott 2020
In addition, Mr. Vellacott and Dr Darrin Disley, Chief Executive
Officer, have exercised options under the Horizon Discovery 2014
Sharesave Scheme over Horizon Discovery Group plc ordinary shares
of 1p each as a result of which their shareholdings have increased
as detailed below:
Number Option Exercise No. of
of options Exercise ordinary
exercised Price shares
and shares held in
retained the Company
following
this transaction
Richard 7 August
Vellacott 10,869 GBP1.656 2017 37,869
Darrin 7 August
Disley 10,869 GBP1.656 2017 725,392
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them.
1 Details of the person discharging managerial
responsibilities / person closely associated
--- ----------------------------------------------------------
a) Name Richard Vellacott
--- ----------------- ---------------------------------------
2 Reason for the notification
--- ----------------------------------------------------------
a) Position/status Chief Financial Officer
--- ----------------- ---------------------------------------
b) Initial Initial notification
notification
/Amendment
--- ----------------- ---------------------------------------
3 Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- ----------------------------------------------------------
a) Name Horizon Discovery Group plc
--- ----------------- ---------------------------------------
b) LEI 213800L812B9NI5M3G89
--- ----------------- ---------------------------------------
4 Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- ----------------------------------------------------------
a) Description Ordinary Shares of GBP0.01 each
of the
financial ISIN: GB00BK8FL363
instrument,
type of
instrument
Identification
code
--- ----------------- ---------------------------------------
b) Nature 1. Grant of options
of the 2. Exercise of options
transaction
--- ----------------- ---------------------------------------
c) Currency GBP
--- ----------------- ---------------------------------------
d) Price(s) Price No. of
and volume(s) shares
------------------ ----------------
1. GBP1.692 1. 10,638
2. GBP1.656 2. 10,869
------------------ ----------------
--- ----------------- ---------------------------------------
e) Aggregated
information
- Aggregated N/A
volume N/A
- Price
--- ----------------- ---------------------------------------
f) Date of 1. 4 August 2017
the transaction
2. 7 August 2017
--- ----------------- ---------------------------------------
g) Place of London Stock Exchange, AIM
the transaction
--- ----------------- ---------------------------------------
1 Details of the person discharging managerial
responsibilities / person closely associated
--- ------------------------------------------------------
a) Name Dr Darrin Disley
--- ----------------- -----------------------------------
2 Reason for the notification
--- ------------------------------------------------------
a) Position/status Chief Executive Officer
--- ----------------- -----------------------------------
b) Initial Initial notification
notification
/Amendment
--- ----------------- -----------------------------------
3 Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- ------------------------------------------------------
a) Name Horizon Discovery Group plc
--- ----------------- -----------------------------------
b) LEI 213800L812B9NI5M3G89
--- ----------------- -----------------------------------
4 Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- ------------------------------------------------------
a) Description Ordinary Shares of GBP0.01 each
of the
financial ISIN: GB00BK8FL363
instrument,
type of
instrument
Identification
code
--- ----------------- -----------------------------------
b) Nature Exercise of options
of the
transaction
--- ----------------- -----------------------------------
c) Currency GBP
--- ----------------- -----------------------------------
d) Price(s) Price No. of shares
and volume(s) ---------- --------------
GBP1.656 10,869
---------- --------------
--- ----------------- -----------------------------------
e) Aggregated
information
- Aggregated N/A
volume N/A
- Price
--- ----------------- -----------------------------------
f) Date of 7 August 2017
the transaction
--- ----------------- -----------------------------------
g) Place of London Stock Exchange, AIM
the transaction
--- ----------------- -----------------------------------
- ENDS -
For further information from Horizon Discovery Group plc, please
contact:
Horizon Discovery Group plc
Darrin Disley, Chief Executive Officer
Richard Vellacott, Chief Financial Officer
Chris Claxton, VP Investor Relations
Tel: +44 (0) 1223 655 580
Numis Securities Limited (Broker and NOMAD)
Michael Meade
Freddie Barnfield
Tom Ballard
Tel: +44 (0) 207 260 1000
Consilium Strategic Communications (Financial Media and Investor
Relations)
Mary-Jane Elliott / Susan Stuart / Matthew Neal / Melissa
Gardiner
Tel: +44 (0) 20 3709 5701
Email: horizon@consilium-comms.com
About Horizon Discovery Group plc www.horizondiscovery.com
Horizon Discovery Group plc (LSE: HZD) ("Horizon"), is a leading
global gene editing company that designs and engineers
genetically-modified cells and then applies them in research and
clinical applications that advance human health.
Horizon's core capabilities are built around its proprietary
translational genomics platform, a highly precise and flexible
suite of gene editing tools (rAAV, ZFN, CRISPR and Transposon) able
to alter almost any gene sequence in human or mammalian
cell-lines.
Horizon offers over 23,000 catalogue products and related
research services, almost all of which are based on the generation
and application of cell and animal models that accurately
recapitulate the disease-causing genetic anomalies found in
diseases like cancer. Horizon's commercial offering has been
adopted by over 1,600 unique research organisations in over 50
countries as well as in the Company's own R&D pipeline to
support a greater understanding of the genetic drivers of disease
and the development of molecular, cell and gene therapies that can
be prescribed on a personalised basis.
Horizon is headquartered in Cambridge, UK, and is listed on the
London Stock Exchange's AIM market under the ticker "HZD".
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHEQLFBDVFEBBV
(END) Dow Jones Newswires
August 07, 2017 02:00 ET (06:00 GMT)
Horizon Discovery (LSE:HZD)
Historical Stock Chart
From Apr 2024 to May 2024
Horizon Discovery (LSE:HZD)
Historical Stock Chart
From May 2023 to May 2024